Environmental endocrine modulators and human health: An assessment of the biological evidence

Critical Reviews in Toxicology

Volumn 28, Issue 2, 1998, Pages 109-227

  Golden, Robert J ^a   Noller, Kenneth L ^b   Titus Ernstoff, Linda ^c   Kaufman, Raymond H ^d   Mittendorf, Robert ^e   Stillman, Robert ^f   Reese, Elizabeth A ^g  

^a Environmental Risk Sciences   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f Shady Grove Fertility Reproductive Science Center   (United States)

^g NATIONAL RESEARCH COUNCIL   (United States)

Author keywords

Chlorinated compounds; DES; Estrogenic effects; PCBs; PCDDs; PCDFs

Indexed keywords

ANTIESTROGEN; DIETHYLSTILBESTROL; ESTROGEN; ORAL CONTRACEPTIVE AGENT; ORGANOCHLORINE DERIVATIVE; PHYTOESTROGEN; XENOBIOTIC AGENT;

BREAST CANCER; CANCER RISK; ENDOCRINE SYSTEM; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; FEMALE INFERTILITY; HEALTH HAZARD; HORMONAL REGULATION; HUMAN; IMMUNOPATHOLOGY; LEARNING DISORDER; MALE GENITAL SYSTEM; MALE INFERTILITY; NONHUMAN; PRENATAL EXPOSURE; PRIMATE; PROSTATE CANCER; REVIEW; SEXUAL BEHAVIOR; TESTIS CANCER; THYROID DISEASE;

ADULT; ANIMALS; ENDOMETRIOSIS; ENVIRONMENTAL POLLUTANTS; FEMALE; GENITALIA, MALE; HUMANS; INFERTILITY; LEARNING DISORDERS; MALE; NEOPLASMS; SEXUAL BEHAVIOR; SEXUAL BEHAVIOR, ANIMAL; THYROID GLAND;

ANIMALIA; PRIMATES;

EID: 0031959301     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408449891344191     Document Type: Review

References (464)

1. Greenspan, F. S. and Baxter, J. D., Basic and Clinical Endocrinology, 4th ed., Appleton and Lange, Norwalk, CT, 1994.
2. Barnes, S., Peterson, G., Grubbs, C., and Setchell, K., Potential role of dietary isoflavones in the prevention of cancer, in Diet and Cancer: Markers, Prevention and Treatment, Jacobs, M. M., Ed., Plenum Press, New York, 1994, 135.
3. Akiyama, T., Ishida, J., Nakagava, S., Ogawara, S., Watanabe, S., Itoh, N., Shiyba, M., and Fukami, Y., Genistein, a specific inhibitor of tyrosine-specific protein kinases, J. Biol. Chem., 262, 5592, 1987.
4. Markowits, J., Couprie, J., Fosse, P., Saucier, J. M., Perre, J., Linassier, C., Larsen, A. K., Lepecq, J. B., and Jacqueminsablon, A., Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II, Can. Res., 49, 5111, 1989.
5. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L., Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc. Natl. Acad. Sci., 90, 2690, 1993.
6. Kelce, W. R., Monosson, E., and Gamcsik, M. P., Environmental hormone disrupters: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites, Toxicol. Appl. Pharmacol, 126, 276, 1994.
7. National Wildlife Federation, Hormone Copycats, Great Lakes Natural Resource Center, Ann Arbor, MI, 1994.
8. Berne, R. M. and Levy, M. N., Physiology, 3rd ed., C.V. Mosby, St. Louis, 1993, 1071.
9. Verdeal, K. and Ryan, D. S., Naturally-occurring estrogens in plant foodstuffs - A review, J. Food Protect., 42, 577, 1979.
10. McLachlan, J. A., Rodent models for perinatal exposure to diethylstilbestrol and their relation to human disease in the male, cited in: Herbst, A. L. and Bern, H. A. Eds., Developmental Effects of Diethylstilbestrol in Pregnancy, Thieme-Stratton, New York, 1981, 148
11. Soto, A. M., Lin, T-M., Justicia, H., Silvia, R. M., and Sonnenschein, C., An "in culture" bioassay to assess the estrogenicity of xenobiotics, cited in: Colbom, T. and Clement, C., Eds., Chemically Induced Alterations in Sexual Development: The Wildlife/Human Connection, Princeton Scientific Publishing, Princeton, NJ, 1992, 295.
12. Soto, A. M., Chung, K. L., and Sonnenshein, C., The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells, Environ. Health Perspect., 102, 380, 1994.
13. Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and McDonnell, D. P., Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay, Tax. Appl. Pharmacol., 143, 205, 1997.
14. Arnold, S.F., Klotz, D. M., Collins, B. M., Vonier, P. M., Guillette, L. J., and McLachlan, J. A., Synergistic activation of estrogen receptor with combinationa of environmental chemicals, Science, 272, 1489, 1996.
15. Ramamoorthy, K., Wang, F., Chen, I.-C., Safe, S., Norris, J. D., McDonnell, D. P., Gaido, K. W., Bocchinfuso, W. P., and Korach, K. S., Potency of combined estrogenic pesticides, Science, 275, 405, 1997a.
16. Ashby, J., Lefevre, P. A., Odum, J., Harris, C. A., Routledge, E. J., and Sumpter, J. P., Synergy between synthetic oestrogens? Nature, 385, 494, 1997.
17. Ramamoorthy, K., Wang, F., Chen, I.-C., Norris, J. D., McDonnell, D. P., Leonard, L. S., Gaido, K. W., Bocchinfuso, W. P., Korach, K. S., and Safe, S., Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: No apparent synergism, Endocrinology, 138, 1520, 1997b.
18. McLachlan, J., Synergistic effect of environmental estrogen: Report withdrawn. Science, 277, 462, 1997.
19. Newbold, R. R., Bullock, B. C., and McLachlan, J. A., Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis, Cancer Res., 50, 7677, 1990.
20. Newbold, R. R. and Bullock, B. C., Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol, Cancer Res., 45, 5145, 1985a.
21. Newbold, R. R. and Bullock, B. C., Progressive proliferative changes in the oviduct of mice following developmental exposure to diethylstilbestrol, Teratogenesis Carcinog. Mutagen., 5, 473, 1985b.
22. McLachlan, J., Newbold, R., and Bullock, B., Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol, Science, 190, 991, 1975.
23. Newbold, R. R., Gender-related behavior in women exposed prenatally to diethylstilbestrol, Environ. Health Perspect., 101, 208, 1993.
24. Newbold, R. R., Cellular and molecualr effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens, Environ. Health Perspect, 103, 83, 1995.
25. Miller, R. K., Perinatal toxicology: Its recognition and fundamentals, Am. J. Ind. Med., 4, 205, 1983.
26. Hogan, M. D., Newbold, R. R., and McLachlan, J. A., Extrapolation of teratogenic responses observed in laboratory animals to humans: DES as an illustrative example, cited in: J. A. McLachlan, J. A., Pratt, R. M., and Markert, C. L., Eds., Developmental Toxicology: Mechanisms and Risks, Banbury Report 26, Cold Spring Harbor Laboratory, Cold Spring Harbor, 1987, 257.
27. Greene, R. R., Burrill, M. W., and Ivy, A. C., Experimental intersexuality, Am. J. Anat., 67, 305, 1940.
28. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for 4,′-DDT, 4,4′-DDE, 4,4′-DDD, United States Department of Health and Human Services, Washington, D. C., 1993a.
29. Dieckmann, W. J. and Davis, M. E., Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am. J. Obstet. Gynecol, 66, 1062, 1953.
30. Stillman, R. J., In utero exposure to diethylstilbestrol: Adverse effects on the reproductive tract and reproductive performance in male and female offspring, Am. J. Obstet. Gynecol., 142, 905, 1982.
31. Giusti, R. M., Iwamoto, K., and Hatch, E. E., Diethylstilbestrol revisited: A review of the long-term health effects, Ann. Intern. Med., 122, 778, 1995.
32. Herbst, A. L., Ulfelden, H., and Poskanzer, D. C., Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women, N. Engl. J. Med., 284, 878, 1971.
33. Bibbo, M. and Gill, W. B., Follow-up study of male and female offspring of DBS-exposed mothers. Obstet. Gynecol., 49, 1, 1977.
34. Whitehead, E. D. and Leiter, E., Genital abnormalities and abnormal semen analysis in male patients exposed to diethylstilbestrol in utero, J. Urol., 125, 47, 1981.
35. Henderson, B. E., Benton, B., and Cosgrove, M., Urogenital tract abnormalities in sons of women treated with diethylstilbestrol, Pediatrics, 58, 505, 1976.
36. Herbst, A. L., Kurman, R. J., and Scully, R. E., Vaginal and cervical abnormalities after exposure to stilbestrol in utero, Obstet. GynelcoL, 40, 287, 1972.
37. Herbst, A. L., Poskanzer, D. C., and Robboy, S. J., Prenatal exposure to stilbestrol: A prospective companion to exposed female offspring with unexposed controls, N. Engl. J. Med., 292, 334, 1975.
38. Herbst, A. L. and Hubby, M. M., Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters, Am. J. Obstet. Gynecol., 141, 1019, 1981.
39. Leary, F. J., Resseguie, L. J., Kurland, L. T., O'Brien, P. C., Emslander, R. F., and Noller, K. L., Males exposed in utero to diethylstilbestrol, J. Amer. Med. Assoc., 252, 2984, 1984.
40. Hadjimichael, O. C. and Meigs, J. W., Cancer risk among women exposed to exogenous estrogens during pregnancy, J. Natl. Cancer Inst, 73, 831, 1984.
41. Labarthe, D., Adam, E., Noller, K. L., O'Brien, P. C., Robboy, S. J., Tilley, B. C., Townsend, D., Barnes, A. B., Kaufman, R. H., Decker, D. G., Fish, C. R., Herbst, A. L., Gundersen, J., and Kurland, L.T., Design and preliminary observations of the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project, Obstet. Gynecol., 51, 453, 1978.
42. Heinonen, O. P., Diethylstilbestrol in pregnancy: frequency of exposure and usage patterns, Cancer, 31, 573, 1973.
43. Gill, W. B., Schumacher, G. F. B., and Bibbo, M., Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities, J. Urol., 122, 36, 1979.
44. Wilcox, A. J., Baird, D. D., Weinberg, C. R., Hornsby, P. P., and Herbst, A. L., Fertility in men exposed prenatally to diethylstilbestrol, N. Eng. J. Med, 332, 1411, 1995.
45. Vessey, M. P., Fairweather, D. V., Norman-Smith, B., and Buckley, J., A randomized double-blind controlled trial of the value of stilboestrol therapy during pregnancy: Long-term follow-up of mothers and their offspring, Br. J. Obstet. Gynecol., 90, 1007, 1983.
46. Report to the Medical Research Council, The use of hormones in the management of pregnancy in diabetics, Lancet, 269, 833, 1955.
47. Ahlborg, U. G., Lipworth, L., Titus-Ernstoff, L., Hsieh, C. C., Hanberg, A., Baron, J., Trichopoulos, D., and Adami, H. O., Organochlorine compounds in relations to breast cancer, endometrial cancer, and endometriosis: An assessment of the biological and epidemilogical evidence, Crit. Rev. Toxicol, 25, 463, 1995.
48. Gellert, R. J., Uterotrophic activity of polychlorinated biphenyls and induction of precocious reproductive aging in neonatally treated female rats, Environ. Res., 16, 123, 1978.
49. Bitman, J. and Cecil, H. C., Estrogenic activity of DDT analogs and polychlorinated biphenyls, J. Agr. Food Chem., 18, 1108, 1970.
50. Jansen, H. T., Cooke, P. S., Porcelli, J., Liu, T. C., and Hansen, L. G., Estrogenic and antiestrogenic actions of PCBs in the female rat: In vitro and in vivo studies, Reprod. Toxicol., 7, 237, 1993.
51. Korach, K. S., Sarver, P., Chae, K., McLachlan, J. A., and McKinney, J. D., Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls conformationally restricted structural probes, Mol. Pharmacol., 33, 120, 1987.
52. Moore, M., Mustain, M., Daniel, K., Chen, I., Safe, S., Zacharewski, T., Gillesby, B., Joyeuxz, A., and Balaguer, P., Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum, Toxical. Appl. Pharmacol. 142, 160, 160, 1997.
53. Krishnan, V. and Safe, S., Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships, Toxicol. Appl. Pharmacol., 120, 55, 1993.
54. Sager, D. B., Effect of postnatal exposure to polychlorinated biphenyls on adult male reproductive function, Environ. Res., 31, 76, 1983.
55. Sager, D. B. and Giraud, D. M., Long-term effects on reproductive parameters in female rats after translactational exposure to PCBs, Environ. Res., 66, 52, 1994.
56. Gellert, R. J., Heinrichs, W. L., and Swerdloff, R. S., DDT homologues: Estrogen-like effects on the vagina, uterus, and pituitary of the rat, Endocrinology, 91, 1095, 1972.
57. Clement, J. G. and Okey, A. B., Estrogenic and antiestrogenic effects of DDT administered in the diet of immature female rats, Can. J. Physiol. Pharmacol., 50, 971, 1972.
58. Duby, R. T., Travis, H. F., and Terrill, C. E., Uterotrophic activity of DDT in rats and mink and its influence on reproduction in the rat, Toxicol. Appl. Pharmacol., 18, 348, 1971.
59. Heinrichs, W. L., Gellert, R. J., Bakke, J. L., and Lawrence, N. L., DDT administered to neonatal rats induces persistent estrus syndrome, Science, 173, 642, 1971.
60. Gellert, R. J., Heinrichs, W. L., and Swerdloff, R., Effects of neonatally-administered DDT homologs on reproductive function in male and female rats, Neuroendocrinology, 16, 84, 1974.
61. Geliert, R. J. and Heinrichs, W. L. Effects of DDT homologs administered to female rats during the perinatal period, Biol. Neonate., 26, 283, 1975.
62. Welsh, R. M., Levin, W., and Conney, A.H., Estrogenic action of DDT and its analogs, Tox. Appl. Pharmacol., 14, 358, 1969.
63. Jobling, S., Reynolds, T., White, R., Parker, M. G., and Sumpter, J. P., A variety of environmentally persistent chemicals, including some phthalte plasticizers, are weakley estrogenic, Environ. Health Perspect., 103, 582, 1995.
64. White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G., Environmentally persistent alkylphenolic compounds are estrogenic, Endocrinology, 135, 175, 1994.
65. Hammond, B., Katzenellenbogen, B. S., Krauthammer and McConnell, J., Estrogenic activity of the insecticide chlordecone (kepone) and interaction with uterine receptors, Proc. Natl. Acad. Sci., 76, 6641, 1979.
66. United States Environmental Protection Agency (EPA), Health Assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds, Vol. I, II, III., EPA/600/BP-92/001c, 1994.
67. United States Environmental Protection Agency (EPA), Health Assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds, Revised Chap. 8, Dose-Response Modeling, 1997.
68. Walker, M. K., Cook, P. M., Butterworth, B. C., Zabel, E. W., and Peterson, R. E., Potency of a complex mixture of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners compared with 2,3,7,8-tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality, Fund. Appl. Toxicol, 30, 178, 1996.
69. Safe, S. H., Environmental and dietary estrogens and human health - Is there a problem? Environ. Health Perspect., 103, 346, 1995.
70. Burroughs, C. D., Bern, H. A., and Stokstad, E. L. R., Prolonged vaginal cornification and other changes in mice treated neonatally with coumestrol, a plant estrogen, J. Toxicol. Environ. Health, 15, 51, 1985.
71. Kuiper-Goodman, T., Scott, P. M., and Watanabe, H., Risk assessment of the mycotoxin zearalenone, Reg. Toxicol. Pharmacol., 7, 253, 1987.
72. Setchell, K. D. R., Borriello, S. P., Hulme, P., Kirk, D. N., and Axelson, M., Nonsteroidal estrogens of dietary origin: Possible roles in hormone-dependent disease, Amer. J. Clin. Nutrition, 40, 569, 1984.
73. Barrett, J., Phytoestrogens: Friends or foes? Environ. Health Perspect., 104, 478, 1996.
74. Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M. Y., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-ross, P. L., Rosenthal, J. F., and Hyer, M. B., Migration patterns and breast cancer risk in Asian-American women, J. Natl. Cancer Inst., 85, 1819, 1993.
75. Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S., Soy intake and cancer risk: A review of the in vitro and in vivo data, Nutr. Cancer, 21, 113, 1994.
76. Baird, D. D., Umbach, D. M., Lansdell, L., Hughes, C. L., Setchell, K. D. R., Weinberg, C. R., Haney, A. F., Wilcox, A. J., and McLachlan, J. A., Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women, J. Clin. Endocrinol. Metab. 80, 1685, 1995.
77. Burroughs, C. D., Bern, H. A., and Stokstad, E. L. R., Reproductive tract abnormalities in female mice exposed neonatally to various doses of coumestrol, J. Toxicol. Environ. Health, 30, 105, 1990.
78. Gray Jr., L. E., Ferrell, J. M., and Ostby, J. S., Alteration of behavioral sex differentiation by exposure to estrogenic compounds during critical neonatal period: Effects of zearalenone, methoxychlor, and estradiol in hamsters, Toxicol. Appl. Pharmacol., 80, 127, 1985.
79. Kaldas, R. S. and Hughes Jr., C. L., Reproductive and general metabolic effects of phytoestrogens in mammals, Reprod. Toxicol., 3, 81, 1989.
80. Whitten, P. L., Lewis, C., and Naftolin, F., A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats, Biol. Reprod., 49, 1117, 1993.
81. Gavaler, J. S., Galvao-Teles, A., Monteiro, E., van Thiel, D. H., and Rosenblum, E., Clinical responses to the administration of bourbon phytoestrogens to normal postmenopausal women, Hepatology, 14, 87A, 1991.
82. Rosenblum, E. R., Campbell, I. M., van Thiel, D. H., and Gavaler, J. S., Isolation and identification of phytoestrogens from beer, Alcohol. Clin. Exp. Res., 16, 843, 1992.
83. Rosenblum, E. R., Stauber, R. E., Van Thiel, D. H., Campbell, I. M., and Gavaler, J. S., Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer, Alcohol. Clin. Exp. Res., 17, 1207, 1993.
84. Schutt, D. A., The effects of plant estrogens on animal reproduction, Endeavor, 35, 110, 1976.
85. Markaverich, B. M., Webb, B., Densmore, C. L., and Gregory, R. R., Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats, Environ. Health Perspect., 103, 574, 1995.
86. Hughes Jr., C. L., Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens. Environ. Health Perspect., 78, 171, 1988.
87. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H., Medical hypothesis: Xenoestrogens as preventable causes of breast cancer, Environ. Health Perspect., 101, 372, 1993.
88. SEER, SEER Cancer Statistics Review: 1973-1990, Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L., Harras, A., Devesa, S. S., and Edwards, B. K., Eds., No. 93-2789, National Cancer Institute, National Institutes of Health, Bethesda, MD, 1993.
89. Lipworth, L., Epidemiology of breast cancer, Eur. J. Cancer Preven., 4, 7, 1995.
90. Houghton, D. L. and Ritter, L., Organochlorine residues and risk of breast cancer, J. Am. Coll. Toxicol., 14, 71, 1995.
91. Harris, J. R., Lippman M. E., and Veronesi U., Breast cancer, Part 1 of 3, New Engl. J. Med., 327, 319, 1992.
92. Trichopoulos, D., Hypothesis: Does breast cancer originate in utero? Lancet, 335 939, 1990a.
93. Trichopoulos, D., Is breast cancer initiated in utero? Editorial, Epidemiol, 1, 95, 1990b.
94. Kelsey, J. L., Breast cancer epidemiology: Summary and future directions. Epid. Rev. 15, 256, 1993.
95. Pollner, F., A holistic approach to breast cancer research, Environ. Health Perspect., 101, 116, 1993.
96. Anon., Risk assessment and religion, Nature Genetics, 11, 105, 1995.
97. Willet, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., Hennekens, C. H., and Speizer, F. E., Dietary fat and the risk of breast cancer, N. Engl. J. Med., 316, 22, 1987.
98. Colditz, G. A., Egan, K. M., and Stampfer, M. J., Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies, Am. J. Obstet. Gynecol., 168, 1473, 1993.
99. Mansfield, C. M., A review of the etiology of breast cancer, J. Nat. Med. Assoc., 85, 217, 1993.
100. Boyd, N. F., Martin, L. J., and Noffel, M., A meta-analysis of studies of dietary fat and breast cancer, Br. J. Cancer, 68, 627, 1993.
101. Yu, H., Harris, R. E., Gao, Y-T., Gao, R., and Wynder, E. L., Comparative epidemiology of cancer of the colon, rectum, prostate and breast in Shanghai, China vs. the United States, Int. J. Epidemiol., 20, 76, 1991.
102. Thomas, D. B. and Karagas, M. R., Cancer in first and second generation Americans, Cancer Res., 47, 5771, 1987.
103. Shimizu, H., Ross, R. K., Bernstein, L., Yatani, R., Henderson, B. E., and Mack, T. M., Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county, Br. J. Cancer, 63, 963, 1991.
104. DeWaard, F. and Trichopoulos, D., A unifying concept of the aetiology of breast cancer, Int. J. Cancer, 41, 666, 1988.
105. Rose, D. P., Goldman, M., and Connolly, J. M., A high-fiber-supplement diet reduces serum estrogen levels in premenopausal women, Am. J. Clin. Nutr., 54, 520, 1991.
106. Adlercreutz, H., Mousavi, Y., and Hockerstedt, K., Diet and breast cancer, Acta. Oncol., 31, 175, 1992.
107. Coward, L., Barnes, N. C., Setchell, K. D. R., and Barnes, S., Genistein, daidzein, and their [beta]-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets, J. Agricul. Food Chem., 41, 1961, 1993.
108. Longnecker, M. P., Paganini-Hill, A., and Ross R. K., Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles, Cancer Epidemiol. Biomarkers Prev., 4, 721, 1995.
109. McGregor, H., Land, C. E., and Choi, K., Breast cancer incidence aming atomic bomb survivors, Hiroshima and Nagasaki, 1950-1969, J. Natl. Cancer Inst., 59, 799, 1977.
110. Palmer, B. D. and Palmer, S. K., Vitellogenin induction by xenobiotic estrogens in the red-eared turtle and African clawed frog, Environ. Health Perspect. Suppl., 103, 19, 1991.
111. Hsieh, C. C and Trichopoulos, D., Breast size, handedness and breast cancer risk, Eur. J. Cancer Clin. Oncol., 27, 131, 1991.
112. Zhang, Z.-F., Vena, J. E., Zielezny, M., Graham, S., Haughey, B. P., Brasure, J., and Marshall, J. R., Occupational exposure to extreme temperature and risk of testicular cancer, Arch. Environ. Health, 50, 13, 1995.
113. Kelsey, J. L. and Horn-Ross, P. L., Breast cancer: Magnitude of the problem and descriptive epidemiology, Epi. Rev., 15, 7, 1993.
114. Robbins, A. S., Brescianini, S., and Kelsey, J. L., Regional differences in known risk factors and the higher incidence of breast cancer in San Francisco, J. Nat. Cancer Inst., 89, 960, 1997.
115. Gilman, A. G., Rail, T. W., Nies, A. S., and Taylor, P., Eds., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. McGraw-Hill, Inc., New York, 1990.
116. Isselbacher, K. J., Braunwald, A. B., Wilson, J. D., Martin, J. B., Fauci, A. S., and Kasper, D. L., Eds., Harrison's Principles of Internal Medicine, 13th ed., McGraw-Hill, New York, 1994, 2496.
117. Miller, D. R., Rosenburg, L. Kaufman, D. W., Stolley, P., Warshauer, M. E., and Shapiro, S., Breast cancer before age 45 and oral contraceptive use: New findings, Am. J. Epidemiol., 129, 269, 1989.
118. Romieu, I., Berlin, J. A., and Colditz, G., Oral contraceptives and breast cancer, review and meta-analysis, Cancer, 66, 2253, 1990.
119. Thomas, E. J., Endometriosis: Still an enigma, Brit. J. Obstet. Gynaecol., 100, 615, 1993.
120. Thomas, B. D., Oral contraceptives and breast cancer: review of the epidemiologic literature, Contraception, 43, 633, 1991.
121. World Health Organization (WHO), Collaborative Study of Neoplasia and Steroid Contraceptives - Breast Cancer and Combined Oral Contraceptives: Results From Multinational Study, Brit. J. Cancer, 61, 110, 1990.
122. Brinton, L. A., Menopause and the risk of breast cancer, Ann. N. Y. Acad. Sci., 592, 357, 1990.
123. Brinton, L. A. and Schairer, C., Estrogen replacement therapy and breast cancer risk, Epi. Rev. 15, 66, 1993.
124. Buring, J. F., Hennekens, C. H., and Lipnick, R. J., A prospective cohort study of postmenopausal hormone use and risk of breast cancer in U. S. women, Am. J. Epidemiol., 125, 939, 1987.
125. Bergkvist, L., Adami, H. O., and Persson, I., The risk of breast cancer after estrogen and strogen-progestin replacement, N. Engl. J. Med. 321, 293, 1989.
126. Yang, C. P., Daling, J. R., and Band, P. R., Noncontraceptive hormone use and risk of breast cancer, Cancer Causes Control., 3, 475, 1992.
127. Key, T. J. and Pike, M. C., Role of estrogens and progestgens in the epidemiology and prevention of breast cancer, Eur. J. Clin. Oncol., 24, 29, 1988.
128. Hunt, K., Long-term effects of postmenopausal hormone therapy, Br. J. Hosp. Med., X, 450, 1987.
129. Ettinger, B., Friedman, G. D., Bush, T., and Quesenberry, C. P., Reduced mortality associated with long-term postmenopausal estrogen therapy, Obstet. Gynecol., 87, 6, 1996.
130. Greenberg, E. R., Barnes, A. B., Resseguie, L., and Barrett, J. A., Breast cancer in mothers given diethylstilbestrol in pregnancy, N. Engl. J. Med., 311, 1393, 1984.
131. Colton, T. and Greenberg, E. R., Breast cancer in mothers prescribed diethylstilbestrol, J. Amer. Med. Assoc., 269, 2096, 1993.
132. Thompson, J. A. and Janench, D. T., Maternal age at birth and risk of breast cancer in daughters, Epidemiology., 1, 101, 1990.
133. Rothman, K. J., MacMahon, B., and Lin, T. M., Maternal age and birth rank of women with breast cancer, J. Natl. Cancer Inst., 65, 719, 1980.
134. Madigan, M. P., Ziegler, R.G., Benichou, J., Byrne, C., and Hoover, R.N., Proportion of breast cancer cases in the United States explained by well-established risk factors, J. Nat. Cancer Inst., 87, 1681, 1995.
135. Brown, N. M. and Lamartiniere, C. A., Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat, Environ. Health Perspect., 103, 708, 1995.
136. Adami, H. O., Berstrom, R., Lund, E., and Meirik, O., Absence of associations between reproductive variables and the risk of breast cancer in young women in Sweden and Norway, Brit. J. Cancer, 62, 122, 1990.
137. Yoo, K. Y., Tajima, K., and Kuroishi, T., Independent protective effect of lactation against breast cancer: A case-control study in Japan, Am. J. Epidemiol., 135, 726, 1992.
138. Newcombe, P. A., Storer, B. E., and Longnecker, M. P., Lactation and a reduced risk of premenopausal breast cancer, N. Engl. J. Med., 330, 81, 1994.
139. Dewailly, E., Ayotte, P., and Brisson, J., Protective effect of breast feeding on breast cancer and body burden of carcinogenic organochlorines, J. Nat. Cancer Inst., 86, 803, 1994.
140. Bradlow, H. L., Davis, D. L., Lin, G., Sepkovic, D., and Tiwari, R., Effects of pesticides on the ratio of 16a/2-hydroxyestrone: A biologic marker of breast cancer risk, Environ. Health Perspect. Suppl., 103, 147, 1995.
141. Murray, F. J. and Edgren, R. A., A critical review of the "good estrogen/bad estrogen" hypothesis and breast cancer; A review for the Chemical Manufacturers Association, Washington, D. C., January 23, 1995.
142. Kimbrough, R. D., Laboratory and human studies on polychlorinated biphenyls (PCBs) and related compounds, Environ. Health Perspect., 59, 99, 1985.
143. National Cancer Institute (NCI), Bioassays of DDT, TDE, and p,p'-DDE for Possible Carcinogenicity, NTIS #PB-286-367, 1978.
144. Rossi, L., Ravera, M., Repetti, G., and Santi, L., Long-term administration of DDT or phenobarbital-Na in Wistar rats, Int. J. Cancer, 19, 179, 1977.
145. Tomatis, L., Turusov, V., and Day, N., The effect of long-term exposure to DDT on CF-1 mice, Int. J. Cancer., 10, 489, 1972.
146. Radomski, J. L. and Fiserova-Bergerova, V., The determination of pesticides in tissues with the electron capture detector without prior clean-up, Ind. Med. Surg., 34, 934, 1965.
147. Cabral, J. R. P. and Hall, R. K., Effects of long term intake of DDT on rats, Tumorigenesis, 68, 11, 1982.
148. Unger, M., Kiaer, H., Blichert-toft, M., Olsen, J., and Clausen, J., Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery, Environ. Res., 34, 24, 1984.
149. Falck, F., Ricci, A. and Godbold, J., Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer, Arch. Environ. Health, 47, 143, 1992.
150. Mussalo-Rauhamaa, H., Hasanen, E., and Pyysalo, H., Occurrence of betahexachlorocyclohexane in breast cancer patients, Cancer, 66, 2124, 1990.
151. Wolff, M. S., Toniolo, P. G., Lee, E. W., Rivera, M., and Dubin, N., Blood levels of organochlorine residues and risk of breast cancer, J. Natl. Cancer Inst., 85, 648, 1993.
152. Krieger, N., Wolff, M. S., and Hiatt, R. A., Breast cancer and serum organochlorines: A prospective study among, black, and Asian women, J. Natl. Cancer Inst., 86, 589, 1994.
153. Hunter, D. J., Hankinson, S. E., Laden, F., Colditz, G. A., Manson, J. E., Willett, W. C., Speizer, F. E., and Wolff, M. S., Plasma organochlorine levels and the risk of breast cancer, N. Engl. J. Med. 337, 1253, 1997.
154. International Agency for Research on Cancer (IARC), Cancer Incidence in Five Continents, Waterhouse, J., Muir, C. and Correa, P., Eds., Scientific Pub. No. 120, 1992.
155. van't Veer, P., Lobbezoo, I. E., Martin-Moreno, J. M., Guallar, E., Gomez-Aracena, J., Kardinaal, A. F. M., Kohlmeier, L., Martin, B. C., Strain, J. J., Thamm, M., van Zoonen, P., Baumann, B. A., Huttunen, J. K., and Kok, F. J., DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study, Brit. Med. J., 315, 81, 1997.
156. Lopez-Carrillo, L., Blair, A., Lopez-Cervantes, M., Cebrian, M., Rueda, C., Reyes, R., Mohar, A., and Bravo, J., Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: A case-control study from Mexico, Can. Res. 57, 3728, 1997.
157. Key, T. and Reeves, G., Organochlorines in the environment and breast cancer, Br. Med. J., 308, 1520, 1994.
158. Brown, D. P., Mortality of workers exposed to polychlorinated biphenyls - An update, Arch. Environ. Health, 42, 333, 1987.
159. Bertazzi, P. A., Riboldi, L., Pesatori, A., Radice, L., and Zocchetti, C., Cancer mortality of capacitor manufacturing workers, Am. J. Indus. Med., 11, 165, 1987.
160. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel, R. A., and Humiston, C. G., Results of a two year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol., 46, 279, 1978.
161. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antiestrogens: Characterization and mechanism of action, Pharmacol. Toxicol., 69, 400, 1991.
162. Porter, W. P., Green, S. M., Debbink, N. L., and Carlson, L, Groundwater pesticides: Ineractive effects of low concentrations of carbamates aldicarb and methomyl and the triazine metribuzin on thyroxine and somatotropin levels in white rats, J. Toxicol. Environ. Health, 40, 15, 1993.
163. Holcomb, M. and Safe, S., Inhibition of 7,12-dimethylbenzathracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Cancer Letters, 82, 43, 1994.
164. Bertazzi, P, A., Pesatori, A. C., and Consonni, D., Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Epidemiology, 4, 398, 1993.
165. Bertazzi, P. A., Pesatori, A. C., and Landi, M.T., Cancer mortality, 1976-1991, in the population exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Organohalogen Compounds, 30, 1996.
166. Mangtani, P., and Booth, M., Epidemiology of endometriosis, J. Epidemiol. Comm. Health 47, 84, 1993.
167. Sangi-Haghpeykar, H. and Poindexter, A. N., Epidemiology of endometriosis among parous women, Obstet. Gynecol., 85, 983, 1995.
168. Olive, D. L. and Barrie Schwartz, L., Endometriosis, New Engl. J. Med., 328, 1759, 1993.
169. Houston, D. E., Noller, K. L., Melton III, L. J., Selwyn, B. J., and Hardy, R. J., The incidence of pelvic endometriosis among women of reproductive age in Rochester, Minnesota, 1970-1979, Am. J. Epidiol., 24, 517, 1979.
170. Wardle, P. G. and Hull, M. G. R., Is endometriosis a disease? Bailliere's Clin. Obstet. Gynecol., 7, 673, 1993.
171. Moen, M. H., Is mild endometriosis a disease? Why do women develop endometriosis and why is it diagnosed? Hum. Reprod., 10, 8, 1995.
172. Sampson, J. A., Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity, Am. J. Obstet. Gynecol., 14, 422, 1927.
173. Sampson, J. A., The development of the implantation theory for the origin of peritoneal endometriosis, Am. J. Obstet. Gynecol., 40, 549, 1940.
174. Moen, M. H. and Magnus, P., The familial risk of endometriosis, Acta. Obstet. Gynecol. Scand., 72, 560, 1993.
175. Simpson, J. L., Elias, S., and Malinak, L. R., Heritable aspects of endometriosis. II. Genetic studies, Am. J. Obstet. Gynecol., 141, 327, 1984.
176. Dmowski, W. P., Gebel, H. M., and Braun, D. P., The role of cell-mediated immunity in pathogenesis of endometriosis, Acta. Obstet. Gynecol. Scand. Suppl., 159, 7, 1994.
177. Vigano, P., Vercellini, P., di Blasio, A. M., Colombo, A., Candiani, G. B., and Vignali, M., Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis, Fertil. Steril., 56, 894, 1991.
178. Oosterlynck, D. J., Cornillie, F. J., Waer. M., Vandeputte, M., and Koninckx, P. R., Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium, Fertil. Steril., 56, 45, 1991.
179. Tanaka, E., Sendo, F., Kawagoe, S., and Hiroi, M., Decreased natural killer activity in women with endometriosis, in Lymphokine-activated killer activity in women with endometriosis, Oosterlynck, D. J., Lacquet, F. A., Waer, M., Koninckx, P. R., Eds., Gynecol. Obstet. Invest., 37, 185, 1992.
180. Kanzaki, H., Wang, H.-S., Kariya, M., and Mori, T., Suppression of natural killer cell activity by sera from patients with endometriosis, Am. J. Obstet. Gynecol., 167, 257, 1992.
181. Oosterlynck, D. J., Meuleman, C., Lacquet, F. A., Waer, M., and Koninckx, P. R., Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis, Am. J. Repro. Immunol., 31, 15, 1994.
182. Wild, R. A., Hirisave, V., Podczaski, E. S., Coulam, C., Shivers, C. A., and Satyaswaroop, P. G., Autoantibodies associated with endometriosis: Can their detection predict presence of the disease? Obstet. Gynecol., 77, 927, 1991.
183. Gilmore, S. M., Aksel, S., Hoff, C., and Peterson, R. D., In vitro lymphocyte activity in women with endometriosis - An altered immune response? Fertil. Steril., 58, 1148, 1992.
184. Gleicher, N., El-Roeiy, A., Confino, E., and Friberg, J., Is endometriosis an autoimmune disease? Obstet. Gynecol., 70, 115, 1987.
185. El-Roeiy, A., Dmowski, W. P., Gleicher, N., Radwanska, E., Harlow, L., Binor, Z., and Tummon, I., Danazol but not GnRH agonists suppresses autoantibodies in endometriosis, Fertil. Steril., 50, 864, 1988.
186. Grosskinsky, C. M. and Halme, J., Endometriosis: The host response, Baillieres Clin. Obstet. Gynecol., 7, 701, 1993.
187. Greydanus, D. E. and Mcanarney, E. R., Menstruation and its disorders in adolescence, Cur. Prob. Pediatr., 1, 1982.
188. Strathy, J. H., Molgaard, C. A., Coulam, C. B., and Melton III, L. J., Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women, Fertil. Steril., 38, 667, 1982.
189. Mahmood, T. A. and Templeton, A., Prevalence and genesis of endometriosis, Human Reprod., 6, 544, 1991.
190. Moen, M. H., Endometriosis in women at interval sterilization, Acta. Obstet. Gynecol. Scand., 66, 451, 1987.
191. Vessey, M. P., Villard-Mackintosh, L., and Painter, R., Epidemiology of endometriosis in women attending family planning clinics, Brit. Med. J., 306, 182, 1993.
192. Royal College of General Practitioners, Oral contraceptives and health: An interim report from the oral contraceptive study of the Royal College of
193. Ramcharan, S., Pellegrin, F. A., Ray, R., and Hsu, J. P., The Walnut Creek contraceptive drug study: a prospective study of the side effects of oral contraceptives. Vol III. Nat. Inst. Health, Center for Population Research Mono., Pub. No. 81-564, 1981.
194. Sutton, G., Hormonal aspects of endometrial cancer, Cur. Opin. Obstet. Gynecol., 2, 69, 1990.
195. Garner, C. H. and Webster, B. W., Endometriosis, J. Obstet. Gynecol. Neonatal Nurs., 14, 10s, 1985.
196. Karansky, K. J., Endometriosis, J. Amer. Med. Assoc., 57, 267, 1955.
197. Stillman, R. J. and Miller, L. R. C., Diethylstilbestrol exposure in utero and endometriosis in infertile females, Fertil. Steril., 41, 369, 1984.
198. Muse, K. N. and Wilson, E. A., How does mild endometriosis cause infertility? Fertil. Steril., 38, 145, 1982.
199. Wheeler, J. M., Johnston, B. M., and Malinak, L. R., The relationship of endometriosis of spontaneous abortion, Fertil. Steril., 39, 656, 1983.
200. Berger, M. J. and Alper, M. M., Intractable primary infertility in women exposed to diethylstilbestrol in utero, Reprod. Med., 31, 231, 1986.
201. Rier, S. E., Martin, D. C., Bowman, R. E., Dmowski, W. P., and Becker, J. L., Endometriosis in rhesus monkeys (Macaca mulatto) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Fund. Appl. Toxicoi, 21, 433, 1993.
202. Arnold, D. L., Nera, E. A., Stapley, R., Tolnai, G., Claman, P., Hayward, S., Tryphonas, H., and Bryce, F., Prevalence of endometriosis in rhesus (Macaca mulatto) monkeys ingesting PCB (Aroclor 1254): Review and evaluation, Fund. Appl. Tox., 31, 42, 1996.
203. McCann, T. O. and Myers, R. E., Endometriosis in rhesus monkeys, Am. J. Obstet. Gynecol., 106, 516, 1970.
204. Hong, R., Taylor, K., and Abonour, R., Immune abnormalities associated with chronic TCDD exposure in Rhesus monkeys, Chemosphere, 18, 313, 1989.
205. Cummings, A. M., Metcalf, J. L., and Birnbaum, L., Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: Time-dose dependence and species comparison, Toxicol. Appl. Pharmacol., 138, 131, 1996.
206. Johnson, K. L., Cummings, A. M., and Birnbaum, L. S., Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls. Environ. Health Perspect. 105, 750, 1997.
207. Alien, J. R., Barsotti, D. A., Van Miller, J. P., Abrahamson, L., and Lalich, J. J., Morphological changes in monkeys consuming a diet containing low levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Food Cosmet. Toxicol., 15, 401, 1977.
208. Barsotti, D. A., Abrahamson, L. J., and Allen, J. R., Hormonal alterations in female rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin, Bull. Environ. Contam. Toxicol. 21, 463, 1979.
209. Kociba, R. J., Keeler, P. A., Park, C. N., and Gehring, P. J., 2,3,7,8-Tetrachlorodibenzo-p-dioxin results of a 13-week oral toxicity study in rats, Toxicol. Appl. Pharmacol., 35, 553, 1976.
210. Bowman, R. E., Schantz, S. L., Weerasinghe, N. C. A., Gross, M. L., and Barsotti, D. A., Chronic dietary intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at 5 or 25 parts per trillion in the monkey: TCDD kinetics and dose-effect estimate of reproductive toxicity, Chemosphere, 18, 243, 1989.
211. Holloway, M., An epidemic ignored: Endometriosis linked to dioxin and immunologie dysfunction, Scientific American, 4, 24, 1994.
212. United States Environmental Protection Agency (EPA), Special report on environmental endocrine disruption: An effects assessment and analysis, EPA/630/R-96/012, 1997.
213. Gerhard, I. and Runnebaum, B., Fertility disorders may result from heavy metal and pesticide contamination which limits effectiveness of hormone therapy, Zentralblatt Fur Gynakalogie, 114, 593, 1992.
214. Carlsen, E., Giwercman, A., Keiding, N., and Skakkebaek, N. E., Evidence for decreasing quality of semen during last 50 years, Brit. Med. J., 305, 609, 1992.
215. Sharpe, R. M., Declining sperm counts in men: Is there an endocrine cause?, J. Endocrinol., 136, 357, 1993.
216. Sharpe, R. M. and Skakkebaek, N. E., Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?, Lancet, 341, 1392, 1993.
217. Ginsburg, K. A. and Armat, D. R., The influence of chamber characteristics on the reliability of sperm concentration and movement measurements obtained by manual and viseomicrographic analysis, Fertil. Steril., 53, 882, 1990.
218. Seaman, E., Bar-Chama, N., and Fisch, H., Semen analysis in the clinical evalua-tion of infertility, Mediguide to Urology, 7, 1, 1994.
219. Johnson, L., Spermatogenesis and aging in humans, J. Androl., 7, 331, 1986.
220. Levine, R. J., Mathew, R. M., and Brandon, C., Differences in the quality of semen in outdoor workers during summer and winter, New Engl. J. Med., 323, 12, 1990.
221. Whorton, M. D. and Meyer, C. R., Sperm count results from 861 American chemical/agricultural workers from 14 separate studies, Fertil. Steril., 42, 82, 1984.
222. Lerda, D., Study of sperm characteristics in persons occupationally exposed to lead, Am. J. Ind. Med., 22, 567, 1992.
223. Wittmaack, F. M. and Shapiro, S. S., Longitudinal study of semen quality in Wisconsin men over one decade, Wisconsin Med. J., 91, 477, 1992.
224. MacLeod, J. and Wang, Y., Male fertility potential in terms of semen quality: a review of the last, a study of the present, Fert. Steril., 31, 103, 1979.
225. Ratcliffe, J. M. and Gladen, B. C., Does early exposure to maternal smoking affect future fertility in adult males?, Reprod. Toxicol., 6, 297, 1992.
226. Paulsen, C. A., Berman, N. G., and Wang, C., Data from men in greater Seattle area reveals no downward trend in semen quality: Further evidence that deterioration of semen quality is not geographically uniform, Fertil. Steril., 65, 1015, 1996.
227. Fisch, H., Feldshuh, J., Goluboff, E. T., Broder, S. J., Oison, J. H., and Barad, D. H., Semen analysis in 1,283 men from the United States over a 25-year period: No decline in semen quality, Fertil. Steril, 65, 1009, 1996.
228. Smith, K. D. and Steinberger, E., What is digosperma? cited in: Troen, P. and Nankin, H. R., Eds., The testis in normal and infertile men, Raven Press, New York, 1977, 489.
229. Fisch, H. and Goluboff, E. T., Geographic variations in sperm counts: A potential cause of bias in studies of semen, Fertil. Steril., 65, 1044, 1996.
230. Auger, J., Kunstmann, J. M., Czyglik, F., and Jouannet, P., Decline in semen quality among fertile men in Paris during the last 20 years, New Engl. J. Med., 332, 281, 1995.
231. Sherins, R. J., Are semen quality and male fertility changing? New Engl. J. Med., 332, 327, 1995.
232. Menkveld, R., Van Zyl, J. A., Kotze, T. J. W., and Joubert, G., Possible changes in male fertility over a 15 year period, Arch. Androl., 27, 143, 1986.
233. Bostofte, E., Serup, J., and Rebbe, H., Has the fertility of Danish men declined during the years in terms of semen quality? A comparison of semen quality between 1952 and 1972. Int. J. Fertil., 28, 92, 1972.
234. Osser, S., Liedholm, P., and Ranstram, J., Depressed semen quality: A survey after two decades, Arch. Androl., 12, 113, 1984.
235. Leto, S. and Frensilli, F. J., Changing parameters of donor semen, Fertil. Steril., 36, 766, 1981.
236. Bendvold, E., Semen quality in Norwegian men over a 20 year period, Int. J. Fertil., 34, 401, 1989.
237. James, W. H., Secular trend in reported sperm counts, Andrologia, 12, 381, 1980.
238. Brake, A. and Krause, W., Decreasing quality of semen, Brit. Med. J., 305, 1495, 1992.
239. Bromwich, P., Cohen, J., Stewart, I., and Walker, A., Decline in sperm counts: An artefact of changed reference range of "normal"?, Brit. Med. J., 309, 19, 1994.
240. Olsen, G. W., Bodner, K. M., Ramlow, J. M., Ross, C. E., and Lipshultz, L. I., Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited, Fertil. Steril., 63, 887, 1995.
241. Mably, T. A., Bjerke, D. L., Moore, R. W., Gendron-Fitzpatrick, A., and Peterson, R. E., In utero and lactational exposure of male rats to 2,3,7,8-tetrachloro-p-dioxin. III. Effects on spermatogenesis and reproductive capacity, Tax. Appl. Pharmcol., 114, 118, 1992.
242. Bjerke, D. L. and Peterson, R. E., Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats: Different effects of in utero vs. lactational exposure, Toxicol. Applied Pharmacol., 127, 241, 1994.
243. Wilker, C., Johnson, L., and Safe, S., Effects of developmental exposures to indole-3-carbinol or 2,3,7,8-tetrachloro-p-dioxin on reproductive potential of male rat offspring, Fund. Appl. Toxicol, 141, 68, 1996.
244. Wolfe, W. H., Michalek, J. E., Miner, J. C., and Rahe, A. J., An epidemiologic investigation of health effects in air force personnel following exposure to herbicides: Extract, reproductive outcomes, executive summary, introduction and conclusions, in Air Force Health Study, Epidemiology Research Division, Armstrong Laboratory, Brooks Air Force Base, TX, 1992.
245. Emmett, E. A., Maroni, M., Jefferys, J., Schmith, J., Levin, B. K., and Alvares, A., Studies of transformer repair workers exposed to PCBs. II. Results of clinical laboratory investigations, Am. J. Ind. Med., 14, 47, 1988.
246. Dalterio, S., Badr, F., Bartke, A., and Mayfield, D., Cannabinoids in male mice: Effects on fertility and spermatogenesis, Science, 216, 315, 1982.
247. Dalterio, S. and Bartke, A., Perinatal exposure to cannabinoids alters male reproductive function in mice, Science, 205, 1420, 1979.
248. 9trahydro-cannabinol in utero exposure on rat off-spring fertility and ventral prostate gland morphology, J. Androl., 6, 386, 1985.
249. Osser, S., Beckman-Ramirez, A., and Liedholm, P., Semen quality or smoking and non-smoking men in infertile couples in a Swedish population, Acta. Obstet. Gynecol. Scand., 71, 215, 1992.
250. John Radcliffe Hospital Cryptorchidism Study Group, Cryptorchidism: An apparent substantial increase since 1960, Br. Med. J., 293, 1401, 1986.
251. John Ratcliffe Hospital Cryptorchidism Study Group, Cryptorchidism: A prospective study of 7,500 consecutive male births, 1985-8, Arch. Dis. Childhood, 67, 892, 1992.
252. Scorer, C. G., The incidence of incomplete descent of the testicle at birth, Arch. Dis. Child., 31, 198, 1956.
253. Berkowitz, G. S., Lapinski, R. H., Dolgin, S. E., Gazella, J. G., Bodian, C. A., and Holzman, I. R., Prevalence and natural history of Cryptorchidism, Pediatrics, 92, 44, 1993.
254. Frey, H. L. and Rajfer, J., Incidence of Cryptorchidism, Urol. Clin. North Am., 9, 327, 1982.
255. Berkowitz, G. S., Lapinski, R. H., Godbold, J. H., and Dolgin, S. E., Maternal and neonatal risk factors for cryptorchidism, Epidemiology, 6, 127, 1995.
256. Anon., An increasing incidence of cryptorchidism and hypospadias? Lancet, I, 1311, 1985.
257. Rozanski, T. A. and Bloom, D. A., The undescended testis: Theory and management, Urol. Clin. North Am., 22, 107, 1995.
258. Beard, M., Melton, L. J., O'Fallon, W. M., Noller, K. L., and Benson, R. C., Cryptorchism and maternal estrogen exposure, Amer. J. Epidemiol., 120, 707, 1984.
259. Andonian, R. W. and Kessler, R., Transplacental exposure to diethylstilbestrol in men, Urology, 8, 276, 1979.
260. Cosgrove, M. D., Benton, B., and Henderson, B. E., Male genitourinary abnormalities and maternal diethylstilbestrol, J. Urol., 177, 220, 1977.
261. Guo, Y. L., Lai, T. J., Ju, S. H., Chen, Y. C., and Hsu, C. C., Sexual developments and biological findings in Yucheng children, cited in: Dioxin '93: 13th International Symposium on Chlorinated Dioxins and Related Compounds, 14, 235, 1993.
262. Guillette, Jr. L. J., Gross, T. S., Massen, G. R., Matter, J. M., Percival, H. F., and Woodward, A. R., Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida, Environ. Health Perspect., 102, 680, 1994.
263. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M., Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist, Nature, 375, 581, 1995.
264. Masuda, Y., Kuroki, H., Yamaryo, T., Haraguchi, K., Karatsune, M., and Hsu, S.T., Comparison of causal agents in Taiwan and Fukuoka PCB poisonings, Chemosphere, 11, 199, 1982.
265. Chen, P. H., Chang, K. T., and Lu, Y. D., Polychlorinated biphenyls and polychlorinated dibenzofurans in the toxic rice-bran oil caused by PCB poisoning in Taichung, Bull. Environ. Contam. Toxicol, 26, 489, 1981.
266. Yoshimura, T. and Hayabuchi, H., Relationship between the amount of rice oil ingested by patients with Yusho and their subjective symptoms, Environ. Health Perspect., 59, 47, 1985.
267. Kuratsune, M., Yusho, with reference to Yu-Cheng, in Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products, 2nd edition, Kimbrough, R. D. and Jensen, A. A., Eds., Elsevier Press, New York, 381, 1989.
268. Kuratsune, M., Masuda, Y., and Nagayama, J., Some of the recent findings concerning Yusho, Proceedings of the National Conference on Polychlorinated Biphenyls, 14, 1976.
269. Masuda, Y., Health status of Japanese and Taiwanese after exposure to contaminated rice oil. Environ. Health Perspect., 60, 321, 1985.
270. Ryan, J. J., Schecter, A., Masuda, Y., and Kikuchi, M., Comparison of PCDDs and PCDFs in the tissues of Yusho patients with those from the general population in Japan and China, Chemosphere, 16, 2017, 1987.
271. Ryan, J. J., Gasiewicz, T. A., and Brown, J. F., Jr. Human body burden of polychlorinated dibenzofurans associated with toxicity based on the Yusho and Yu-Cheng incidents, Fund. Appl. Toxicol., 15, 722, 1990.
272. Guo, Y. L., Lin, C. J., and Yao, W. J., Musculoskeletal changes in children prenatally exposed to polychlorinated biphenyls and related compounds (Yu-Cheng children), J. Toxicol. Environ. Health, 41, 83, 1994a.
273. Guo, Y. L., Chen, Y. C., Yu, M. L., and Hsu, C. C., Early development of Yu-Cheng children born seven to twelve years after the Taiwan PCB outbreak, Chemosphere, 29, 2395, 1994b.
274. Masuda, Y., Approach to risk assessment of chlorinated dioxins from Yusho PCB poisoning, Organohalogen Compounds, 21, 1, 1994.
275. Bruckner, J. V., Letter, to Agency for Toxic Substances and Disease Registry, Division of Toxicology, Atlanta, GA, May 4, 1993.
276. Guyton, A. C., Textbook of Medical Physiology, 2nd ed., W. B. Saunders, Philadelphia, PA, 1180, 1961.
277. Gray Jr., L. E., Ostby, J. S., and Kelce, W. R., Developmental effects of an environmental antiandrogen: The fungicide vinclozolin alters sex differentiation of the male rat, Toxicol. Appl. Pharmacol., 129, 46, 1994.
278. Wagner, M. G. and Stephenson, P. A., Infertility in industrialized countries: Prevalence and prevention, Soz Praventivmed, 37, 213, 1992.
279. World Health Organization (WHO), Steep decline in world fertility rates: Contraceptive use up sharply, Soz Praventivmed, 37, 254, 1992.
280. Leke, R. J., Oduma, J. A., Bassol-Mayagoitia, S., Bacha, A. M., and Grigor, K. M., Regional and geographical variations in infertility: Effects of environmen-tal, cultural, and socioeconomic factors, Environ. Health Perspect., 101, Suppl. 2, 73, 1993.
281. Olsen, J., Is human fecundity declining - and does occupational exposures play a role in such a decline if it exists?, Scand. J. Work Environ. Health, 20, 72, 1994.
282. Swerdloff, R. S., Infertility in the male, Ann. Intern. Med., 103, 906, 1985.
283. Lundsberg, L. S., Bracken, M. B., and Belanger, K., Occupationally related magnetic field exposure and male subfertility, Fert. Steril., 63, 384, 1995.
284. Westrom, L. V., Environmentally persistent alkylphenolic compounds are estrogenic, Sex Transm. Dis. Suppl. 21, S32, 1994.
285. Thonneau, P., Ducot, B., and Spira, A., Risk factors in men and women consulting for infertility, Int. J. Fertil. Menopausal Stud., 38, 37, 1993.
286. Steeno, O. P. and Pangkahila, A., Occupational influences on male infertility and sexuality, Andrologia, 16, 22, 1984.
287. Schrag, S. D. and Dixon, R. L., Occupational exposures associated with male reproductive dysfunction, Ann. Rev. Pharmacol. Toxicol. 25, 567, 1985.
288. Witkin, S. S., Jeremias, J., Grifo, J. A., and Ledger, W. J., Detection of chlamydia trachomatis in semen by the polymerase chain reaction in male members of infertile couples, Am. J. Obstet. Gynecol., 168, 1457, 1993.
289. Wolff, H., Neubert, U. and Zebhauser, M., Bezold, G., Korting, H. C., and Meurer, M., Chlamydia trachomatic induces an inflammatory response in the male genital tract and is associated with altered semem quality, Fertil. Steril., 55, 1017, 1991.
290. Micic, S., Petrovic, S., and Dotlic, R., Seminal antisperm antibodies and genitourinary infection, Urology, 8, 54, 1990.
291. Bracken, M. B., Eskenazi, B., Sachse, K., McSharry, J. E., Hellenbrand, K., and Summers, L. L., Association of cocaine use and sperm concentration, motility and morphology, Fertil. Steril., 53, 315, 1990.
292. Stenchever, M. A., Williamson, R. A., Leonard, J., Karp, L. E., Ley, B., Shy, K., and Smith,D., Possible relationship between in utero diethylstilbestrol exposure and male fertility, Am. J. Obstet. Gynecol., 140, 186, 1981.
293. Shy, K. K., Stenchever, M. A., Karp, L. E., Berger, R. E., Williamson, R. A., and Leonard, J., Genital tract examinations and zona-free hamster egg penetration tests from men exposed in utero to diethylstilbestrol, Fertil. Steril., 42, 772, 1984.
294. Pines, A., Cucos, S., Ever-Hardani, P., and Ron, M., Some organochlorine insecticide and polychlorinated biphenyl blood residues in infertile males in the general Israeli population of the middle 1980s, Arch. Environ. Contam. Toxicol., 16, 587, 1987.
295. Kaufman, R. H. and Binder, G. L., Upper genital tract changes associated with exposure in utero to diethylstilbestrol, Am. J. Obstet. Gynecol., 128, 51, 1977.
296. Kaufman, R. H., Noller, K., Adam, E., Irwin, J., Gray, M., Jefferies, J. A., and Hilton, J., Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny, Obstet. Gynecol., 148, 973, 1984.
297. Kaufman, R. H., Adam, E., Noller, K., Irwin, J. F., and Gray, M., Upper genital tract changes and infertility in diethylstilbestrol-exposed women, Am. J. Obstet. Gynecol, 154, 1312, 1986.
298. Barnes, A. B., Menstrual history of young women exposed in utero to diethylstilbestrol, Fertil. Steril, 32, 148, 1979.
299. Barnes, A., Colton, T., and Gunderson, J., Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol, N. Engl. J. Med., 302, 609, 1980.
300. Barnes, A. B., Menstrual history and fecundity of women exposed and unexposed in utero to DES, J. Reprod. Med., 29, 651, 1984.
301. Herbst, A. L. and Bern, H. A., Eds., Developmental Effects of Diethylstilbestrol in Pregnancy, Thieme-Stratton, New York, 1982.
302. Cousins, L., Karp, W., Lacey, C., and Lucas, W. E., Reproductive outcome of women exposed to diethylstilbestrol in utero, Obstet. Gynecol., 56, 70, 1980.
303. Senekjian, E. K., Potkul, R. K., Frey, K., and Herbst, A. L., Infertility among daughters either exposed or not exposed to diethylstilbestrol, Am. J. Obstet. Gynecol., 158, 493, 1988.
304. Berger, M. J. and Goldstein, D. P., Impaired reproductive performance in DES-exposed women, Obstet. Gynecol., 55, 25, 1980.
305. Jefferies, J. A., Robboy, S. J., O'Brien, P. C., Bergstralh, E. J., Labarthe, D. R., Barnes, A. B., Noller, K. L., Hatab, P. A., Kaufman, R. H., and Townsend, D. E., Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) project, Am. J. Obstet. Gynecol., 148, 59, 1984.
306. Schmidt, G., Fowler, W. C., Talbert, L. M., and Edelman, D. A., Reproductive history of women exposed to diethylstilbestrol in utero, Fertil. Steril., 33, 21, 1980.
307. Ben-Baruch, G., Menczer, J., Mashiach, S., and Serr, D. M., Uterine anomalies in diethylstilbestrol-exposed women with fertility problems, Acta Obstet. Gynecol. Scand., 60, 395, 1981.
308. Goldstein, D. P., Incompetent cervix in offspring exposed to diethylstilbestrol in utero, Obstet. Gynecol., 52, 735, 1978.
309. O'Brien, P. C., Noller, K. L., and Robboy, S. J., Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project, Obstet. Gynecol., 53, 300, 1979.
310. Bibbo, M., Haenszel, W. M., and Wied, G. L., A twenty-five year follow-up study of women exposed to diethystilbestrol during pregnancy, N. Engl. J. Med., 298, 763, 1978.
311. Veridiano, N. P., Delke, L, Rogers, J., and Tancer, M. L., Reproductive performance of DBS-exposed female progeny, Obstet. Gynecol., 58, 58, 1981.
312. Leoni, V., Fabiani, L., Marinelli, G., and Puccetti, G., PCB and other organochlorine compounds in blood in women with or without miscarriage: A hypothesis of correlation, Ecotoxicol. Environ. Safety, 17, 1, 1989.
313. Kimbrough, R. D., Polychlorinated biphenyls (PCBs) and human health: An update, Crit. Review. Toxicol., 25, 133, 1995.
314. Byne, W. and Parsons, B., Human sexual orientation: The biologic theories reappraised, Arch. Gen. Psychiatry, 50, 228, 1993.
315. Kester, P., Green, R., Finch, S. J., and Williams, K., Prenatal female hormone administration and psychosexual development in human males. Psychoneuroendocrinology, 5, 269, 1980.
316. Reinisch, J. M., Ziemba-Davis, M., and Sanders, S. A., Hormonal contributions to sexually dimorphic behavioral development in humans, Psychoneuroendocrinology, 16, 213, 1991.
317. Meyer-Bahburg, H. F., Ehrhardt, A. A., Rosen, L. R., Gruen, R. S., Veridiano, N. P., Vann, F. H., and Neuwalder, H. F., Prenatal estrogens and the development of homosexual orientation, Develop. Psych., 31, 12, 1995.
318. Hines, M., Prenatal gonadal hormones and sex differences in human behavior, Psychol. Bull., 92, 56, 1982.
319. Grisham, W., Kerchner, M., and Ward, I. L., Prenatal stress alters sexually dimorphic nuclei in the spinal cord of male rats, Brain Res., 551, 126, 1991.
320. Velazquez-Moctezuma, J., Dominguez Salazar, E.,and Cruz Rueda, M. L., The effect of prenatal stress on adult sexual behavior in rats depends on the nature of the Stressor, Physiol. Behav., 53, 443, 1993.
321. Hermans, R. H., McGivern, R. F., Chen, W., and Longo, L. D., Altered adult sexual behavior in the male rat following chronic prenatal hypoxia, Neurotoxicol. Teratol., 15, 353, 1993.
322. Ward, I. L. and Weisz, J., Maternal stress alters plasma testosterone in fetal males, Science, 207, 328, 1980.
323. Ward, I. L. and Stehm, K. E., Prenatal stress feminizes juvenile play patterns in male rats, Physiol. Behav., 50, 601, 1991.
324. Lichtensteiger, W. and Schlumpf, M., Prenatal nicotine affects fetal testosterone and sexual dimorphism of saccharin preference, Pharmacol. Biochem. Behav., 23, 439, 1985.
325. McGivern, R. F., Clancy, A. N., Hill, M. A., and Noble, E. P., Prenatal alcohol exposure alters adult expression of sexually dimorphic behavior in the rat, Science, 224, 896, 1984.
326. Parker, S., Udani, M., Gavaler, J. S., and Van Thiel, D. H., Adverse effects of ethanol after the adult sexual behavior of male rats exposed in utero, Neurobehav. Toxicol. Teratol., 6, 289, 1984.
327. Raum, W. J. McGivern, R. F., Peterson, M. S. Shryne, J. H., and Forski, R. A., Prenatal inhibition of hypothalamic sex steroid uptake by cocaine: Effects on neurobehavioral sexual differentiation in male rats, Develop. Brain Res., 53, 230, 1990.
328. Udani, M., Parker, S., Favaler, J., and van Thiel, D. H., Effects of in utero exposure to alcohol after male rats, Alcohol. Clin. Exp. Res., 9, 355, 1985.
329. Pizzi, W. J., Barnhart, J. E., and Fanslow, D. J., Monosodium glutamate administration to the newborn reduces reproductive ability in female and male mice, Science, 196, 452, 1977.
330. Hsu, C. C., Hu, H. F., Lai, T. J., Ko, H. C., and Chen, Y. C., Behavioral development of Yucheng children as compared with their matched controls, in Dioxin '93: 13th International Symposium on Chlorinated Dioxins and Related Compounds, 14, 239, 1993.
331. Hovinga, M. E., Sowers, M., and Humphrey, H. E. B., Histological changes in serum PCB and DDT levels in an environmentally exposed cohort, A rch. Environ. Contam. Toxicol., 22, 362, 1992.
332. Massachusetts Department of Public Health, Final report of Greater New Bedford PCB Health Effects Study 1984-1987, Boston, MA, 1987.
333. Humphrey, H. E. B., Population studies of PCBs in Michigan residents, in Human and Environmental Hazards, D'Itri, F. M. and Kamrin, M., Eds., Butterworth, Boston, 1983, 299.
334. Cole, D. C., Kearney, J., Gilman, A. P., and Ryan., J. J., Serum PCB, dioxin and furan levels in Ontario Great Lakes Anglers, Organohalogen Compounds, 26, 193, 1995.
335. Kreiss, K., Studies of population exposed to polychlorinated biphenyls, Environ. Health Perspect., 60, 193, 1985.
336. Chen, Y. C., Guo, Y. L., Hsu, C. C., and Rogan, W. J., Cognitive development of Yu-Cheng children prenatally exposed to heat-degraded PCBs, J. Amer. Med. Assoc., 268, 3213, 1992.
337. Truscott, S. D., Narrett, C. M., and Smith, S. E., WISC-R subtest reliability over time: Implications for practice and research, Psychol. Rep., 74, 147, 1994.
338. Lai, T. J., Guo, Y. L., Yu, M. L., and Ko, H. C., Cognitive development in Yu Cheng children, Chemosphere, 29, 2405, 1994.
339. Guo, Y. L., Lai, T. J., Chen, S. J., and Hsu, C. C., Gender-related decrease in raven's progressive matrices scores in children prenatally exposed to polychlorinated biphenyls and related compounds, Bull. Environ. Contam. Toxicol., 55, 8, 1995.
340. Guo, Y. L., Yu, M. M., and Ryan, J. J., Different congeners of PCBs/PCDFs may have contributed to different health outcomes in the Yucheng cohort, Neurotox. Teratol., 18, 255, 1996.
341. Yu, M. L., Hsu, C. C., and Guo, Y. L., Disordered behavior in the early-bom Taiwan Yu-Cheng children, Chemosphere, 29, 2413, 1994.
342. Tanabe, S., Kannan, N., Wakimoto, T., Tatsukawa, R., and Okamoto, T., Isomer specific determination and toxic evaluation of potentially hazardous coplanar PCBs, dibenzofurans, and dioxins in the tissues of "Yusho" PCB poisoning victim and in the causal oil, Toxicol. Environ. Chem., 24, 215, 1989.
343. Fein, G. G., Jacobson, J. L., Jacobson, S. W., Schwartz, P. M., and Dowler, J. K., Prenatal exposure to polychlorinated biphenyls: Effects on birth size and gestational age, J. Pediatrics, 105, 315, 1984.
344. Jacobson, J. L., Fein, G. G., Schwartz, P. M., and Dowler, J. K., Prenatal exposure to an environmental toxin: A test of the multiple effects model, Develop. Psychol., 20, 523, 1984.
345. Jacobson, S. W., Fein, G. G., Jacobson, J. L., Schwartz, P. M., and Dowler, J. K., The effects of intrauterine PCB exposure on visual recognition memory, Child Dev., 56, 853, 1985.
346. Jacobson, J. L., Jacobson, S. W., and Humphrey, H. E. B., Effects of exposure to PCBs and related compounds on growth and activity in children, Neurotox. Teratol., 12, 319, 1990a.
347. Jacobson, J. L., Jacobson, S. W., and Humphrey, H. E. B., Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children, J. Pediatrics, 116, 38, 1990b.
348. Schwartz, P. M., Jacobson, S. W., Fein, G., Jacobson, J. L., and Price, H. A., Lake Michigan fish consumption as a source of polychlorinated biphenyls in human cord serum, maternal serum, and milk, Amer. J. Pub. Health, 73, 293, 1983.
349. Paneth, N., Human reproduction after ingestion of PCB-contaminated fish, Health Environ. Digest, 5, 4, 1991.
350. Swain, W. R., Effect of organochlorine chemicals on the reproductive outcome of humans who consumed contaminated Great Lakes fish: An epidemiologic consideration, J. Toxicol. Environ. Health, 33, 587, 1991.
351. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Mercury, United States Department of Health and Human Services, Washington, D. C., 1993b.
352. Dar, E., Kanarek, M. S., Anderson, H. A., and Sonzogni, W. C., Fish consumption and reproductive outcomes in Green Bay, Wisconsin, Environ. Res., 59, 189, 1992.
353. Rogan, W. J., Gladen, B. C., and McKinney, J. D., Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethane (DDE) in human milk: Effects of maternal factors and previous lactation, Am. J. Health, 76, 172, 1986a.
354. Rogan, W. J., Gladen, B. C., Mckinney, J. D., Carreras, N., Hardy, P., Thullen, J., Tinglestad, J., and Tully, M., Neonatal effects of transplacental exposure to PCBs and DDE, J. Pediatr., 8, 335, 1986b.
355. Gladen, B. C., Rogan, W. J., Hardy, P., Thullen, J., Tinglestad, J., and Tully, M., Development after exposure to polychlorinated biphenyls and dichlorophenyl dichloroethene transplacentally and through human milk, J. Pediatr., 113, 991, 1988.
356. Gladen, B. C. and Rogan, W. J., Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethane on later development, J. Pediatr., 119, 58, 1991.
357. Brazelton, T. B., Nugent, J. K., and Lester, B. M., Neonatal Behavioral Assessment Scale, Lippincott, Philadelphia, 780, 1973.
358. Lonky et Lonkey, E., Reihman, J., Darvill, T., Mather, J., and Daly, H., Neonatal behavioral assessment scale performance in humans influenced by maternal consumption of environmentally contaminated Lake Ontario fish, J. Great Lakes Res., 22, 198, 1995.
359. Safe, S. H., Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment, Crit. Rev. Toxicol., 24, 87, 1994.
360. Schantz, S. L., Developmental neurotoxicity of PCBs in humans: What do we know and where do we go from here?, Neurotox. Teratol., 18, 217, 1996.
361. Koopman-Esseboom, C., Morse, D. C., Weisglas-Kuperus, N., Lutkeschipholt, I. J., van der Paauw, C. G., Tuinstra, L. G. M. T., Brouwer, A., and Sauer, P. J. J., Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants, Pediatric Research, 36, 468, 1994.
362. Bowman, R. E., Hieonimus, M. P., and Allen, J. R., Correlation of PCB body burden with behavioral toxicology in monkeys, Pharmacol. Biochem. Behav., 9, 49, 1978.
363. Mele, P. C., Bowman, R. E., and Levin, E. D., Behavioral evaluation of perinatal PCB exposure in rhesus monkeys: fixedinterval performance and reinforcement-omission, Neurobehav. Tox. Teratol., 8, 131, 1986.
364. Levin, E. D., Schantz, S. L., and Bowman, R. E., Delayed spatial alternation deficits resulting from perinatal PCB exposure in monkeys, Arch. Toxicol., 62, 267, 1988.
365. Schantz, S. L. and Bowman, R. E., Learning in monkeys exposed perinatally to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD), Neurotox. Teratol., 11, 13, 1989.
366. Bowman, R. E., Schantz, S. L., Ferguson, S. A., Tong, H. Y., and Gross, M. L., Controlled exposure of female Rhesus monkeys to 2,3,7,8-TCDD: Cognitive behavioral effects in their offspring, Chemosphere 20, 1103, 1990.
367. Swerdlow, A. J., The epidemiology of testicular cancer, Eur. Urol. Suppl. 23, 35, 1993.
368. Osterlind, A., Diverging trends in incidence and mortality of testicular cancer in Denmark, Brit. J. Cancer, 53, 501, 1986.
369. Moller, H., Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology, Eur. Urol., 23, 8, 1993.
370. Bergstrom, R., Adami, H.-O., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., and Hakulinen, T., Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon, J. Natl. Cancer Inst., 88, 727, 1996.
371. Boyle, P. and Zaridze, D. G., Proceedings: Risk factors for prostate and testicular cancer, Eur. J. Cancer, 29A, 1048, 1993.
372. Ross, R. K., Mccurtis, J. W., Henderson, B. E., Menck, H. R., Mack, T. M., and Martin, S. P., Descriptive epidemiology of testicular and prostatic cancer in Los Angeles, Br. J. Cancer, 39, 284, 1979.
373. Fram, R. J., Garnick, M. B., and Retik, A., The spectrum of genitourinary abnor-malities in patients with cryptorchidism, with emphasis on testicular carcinoma, Cancer, 50, 2243, 1982.
374. Henderson, B. E., Benton, B., Jing, J., Yu, M. C., and Pike, M. C., Risk factors for cancer of the testis in young men, Int. J. Cancer, 23, 598, 1979.
375. Morrison, A. S., Cryptorchidism, hernia, and cancer of the testis, J. Natl. Cancer Inst., 56, 731, 33, 1976.
376. Kuber, W., Testicular tumor and cryptorchidism, Eur. Urol., 8, 280, 1982.
377. Moss, A. R., Osmond, D., Bacchetti, P., Torti, F. M., and Gurgin, V., Hormonal risk factors in testicular cancer, Amer. J. Epid., 124, 39, 1986.
378. Depue, R. H., Pike, M. C., and Henderson, B. E., Estrogen exposure during gestation and risk of testicular cancer, J. Natl. Can. Inst., 71, 1151, 1983.
379. DeLeval, J. and Vandeberg, C., Testis tumor: The problem of the undescended testis, JBR-BTR, 76, 100, 1993.
380. United Kingdom Testicular Cancer Study Group (UKTCSG), Aetiology of testicular cancer: Association with congenital abnormalities, age at puberty, infertility, and exercise, Brit. Med. J., 308, 1393, 1994.
381. Thune, I. and Lund, E., Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men, Cancer Causes Con., 5, 549, 1994.
382. Verreault, R., Weiss, N. S., Hollenbach, K. A., Strader, C. H., and Daling, J. R., Use of electric blankets and risk of testicular cancer. Am. J. Epidemiol., 131, 759, 1990.
383. Bullock, B. C., Newbold, R. R., and McLachlan, J. A., Lesions of testis ad epididymis associated with prenatal diethylstilbestrol exposure, Environ. Health Perspect., 77, 29, 1988.
384. Gershman, S. T. and Stolley, P. D., A case-control study of testicular cancer using Connecticut tumour registry data, Int. J. Epidemiol., 17, 738, 1988.
385. Conley, G. R., Sant, G. R., and Ucci, A. A., Seminoma and epidymal cysts in a young man with known diethylstilbestrol exposure in utero, J Amer. Med. Assoc., 249:1325-6. 1983
386. Rajpert-De Meyts, E., and Skakkeboek, N. E., The possible role of sex hormones in the development of ttesticular cancer, Eur. Urol., 23, 54, 1993.
387. Braun, M. M., Ahlbom, A., Floderus, B., Brinton, L. A., and Hoover, R. N., Effect of twinship on incidence of cancer of the testis, breast, and other sites, Cancer Causes and Control, 6, 519, 1995.
388. Pylkkanen, L., Jahnukainen, K., and Santti, R., Testicular toxicity and mutagenicity of steroidal and non-steroidal estrogens in the male mouse, Mut. Res., 261, 181, 1991.
389. Potosky, A. L., Miller, B. A., Albertsen, P. C., and Kramer, B. S., The role of increasing detection in the rising incidence of prostate cancer, J. Am. Med. Assoc., 273, 548, 1995.
390. McCaul, K. A., Luke, C. G., and Roder, D. M., Trends in prostate cancer incidence and mortality rates in South Australia, 1977-1993, Med. J. Aust., 162, 520, 1995.
391. DeVito, M. J., Maier, W. E., Delberto, J. J., and Birnbaum, L. S., Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment, Fund. Appl. Toxicol., 20, 125, 1993.
392. Gardner W. A., Jr. and Bennett, B. D., The prostate-Overview: Recent insights and speculations, Mono. Pathol., 34, 129, 1992.
393. Bosland, M. C., Animal models for the study of prostate carcinogenesis, J. Cell. Biochem. Suppl. 16H, 89, 1992a.
394. Bosland, M. C., Dreef-Van Der Muslen, H. C., Sukumar, S., Ofner, P., Leav, I., Han, X., and Liehr, J. G., Multistage prostate carcinogenesis: the role of hormones, in Multistage Carcinogenesis,CRC Press, Boca Raton, 1992b, 109.
395. Santti, R., Pylkkanen, L., Newbold, R., and McLachlan, J. A., Editorial: Developmental oestrogenization and prostatic neoplasia, Int. J. Androl., 13, 77, 1990.
396. Santti, R., Newboldmark, R. R., Makela, S., Pylkkanen, L., and Mclachlan, J. A., Developmental estrogenization and prostatic neoplasia, Prostate, 24, 67, 1994.
397. National Cancer Institute (NCI), National Cancer Institute roundtable on prostate cancer: future research directions, Chiarodo, A. (Ed), Can. Res., 51, 2498, 1991.
398. Shirai, T., Imaida, K., Masui, T., and Iwasaki, S., Effects of testosterone, dihydrotestosterone and estrogen on 3,2′-dimethyl-4-aminobiphenyl-induced rat prostate, Int. J. Cancer, 57, 224, 1994.
399. DeVita, V. T., Hellman, S., and Rosenberg, S. A., Cancer: Principles and Practice of Oncology, 4th ed., J. B. Lippincott, Philadelphia, PA, 1993.
400. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Chlorinated Dibenzo-p-Dioxins, United States Department of Health and Human Services, Washington, D. C., 1996.
401. Reijnders, P. J., Toxicokinetics of chlorobiphenyls and associated physiological responses in marine mammals, with particular reference to their potential for ecotoxicological risk assessment, Sci Total Environ., 154, 229, 1994.
402. Deguise, S., Martineau, D., Beland, P., and Fournier, M., Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Delphinapterus leucas), Environ. Health Perspect., 103, 73, 1995.
403. Klein, P. A., Immunology and biotechnology for the study and control of infectious diseases in wildlife populations, J. Zoo Wildlife Med., 24, 346, 1993.
404. Stites, D. P, Terr, A. I., and Parslow, T. G., Eds., Basic and Clinical Immunology, 8th ed., Appleton and Lange, Norwalk, CT., 1994, 870.
405. Ways, S. C. and Mortola, J. F., Alterations in immune responsiveness in women exposed to diethylsilbestrol in utero. Fertil. Steril. 48, 193, 1987.
406. Ford, C. D., Johnson, G. H., and Smith, W. G., Natural killer cells in utero diethylstilbestrol-exposed patients, Gynecol. Oncol., 16, 400, 1983.
407. Wingard D. L. and Turiel, J., Long-term effects of exposure to DES, Western J. Med., 149, 551, 1988.
408. Noller, K. L., Blair, P. B., O'Brien, P. C., Melton III, L. J., Offord, J. R., Kaufman, R. H., and Colton, T., Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol, Fertil. Steril., 49, 1080, 1988.
409. Blair, A., Linos, A., Stewart, P.A., Burmeister, L., Gibson, R., Everett, G., Shumann, L., and Cantor, K. P., Comments on Occupational and Environmental Factors in the Origin of Non-Hodgkin's Lymphoma, Cancer Research, 52, 5501, 1992.
410. Helgason, S. and Schoultz, B. V., Estrogen replacement therapy and mixed lymphocyte reaction, Amer. J. Obstet. Gynecol., 141, 393, 1981.
411. Kalland, T., Alterations of antibody response in female mice after neonatal exposure to diethylstilbestrol, J. Immunol, 124, 194, 1980a.
412. Kalland, T., Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol, Immunol., 124, 1297, 1980b.
413. Kalland, T., Decreased and disproportionate T cell population in adult mice after neonatal exposure to diethylstilbestrol, Cell, Immunol., 51, 55, 1980c.
414. Kalland, T. and Forsberg, J-G., Natural killer cell activity and tumor susceptibility in female mice treated neonally with diethystilbestrol, Cancer Res., 41, 5134, 1981.
415. Kalland, T., Long-term effects on the immune system of an early life exposure to diethylstilbestrol, In Environmental Factors in Human Growth and Development, Banbury Report 11., Hunt, V. R., Smith, M. K., and Worth, D., Eds., Cold Spring Harbor Laboratory, 217, 1991.
416. Kalland, T., Fossberg, T. M., and Forsberg, J.G., Effect of estrogen and corticosterone on the lymphoid system in neonatal mice, Exper. Mol. Path., 28, 76, 1978.
417. Luster, M., Faith, R., McLachlan, J., and Clark, G., Effect of in utero exposure to diethylstilbestrol on the immune response in mice, Toxicol. Appl. Pharmacol., 47, 279, 1979.
418. Blair, P. B., Immunological consequences of early exposure of mice to diethylstilbestrol, cited in: Clinical Practice of Gynecology, 2nd ed. Eisevier, New York, 1990, 91.
419. Ways, S. C., Blair, P. B., Bern, H. A., and Staskawicz, M. O., Immune responsiveness of adult mice exposed neonatally to diethylstilbestrol, steroid hormones, or vitamin A, J. Env. Path. Toxicol., 3, 207, 1980.
420. Kalland, T., Strand, O., and Forsberg, J. G., Longterm effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes, J. Natl. Cancer Inst., 63, 413, 1979.
421. Blair, P. B., Immunological consequences of early exposure of experimental rodents to diethylstilbestrol and steroid hormones, cited in: Bern, H. A. and Herbst, A. L., Eds., Developmental Effects of Diethylstilbestrol (DES) in pregnancy, Thieme-Statton, New York, 1981, 167.
422. Tryphonas, H., Immunotoxicity of polychlorinated biphenyls: Present status and future considerations, Exp. Clin. Immunogenet., 11, 149, 1994.
423. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Polychlorinated Biphenyls, United States Department of Health and Human Services, Washington, D. C., 1995.
424. International Programme on Chemical Safety (IPSC), Persistent organic pollutants: An assessment report on DDT-aldrin-dieldrin-endrin-chlordane-hep-tachlor-hexachlorobenzene-mirex- toxaphene-polychlorinated biphenyls-dioxins and furans, Inter-Organizational Programme for the Sound Management of Chemicals, 1995.
425. Smialowicz, R. J., Riddle, M. M., Williams, W. C., and Diliberto, J. J., Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: Differences between mice and rats, Toxicol. Appl. Pharmacol, 124, 248, 1994.
426. Fan, F., Wierda, D., and Rozman, K. K., Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats, Toxicology, 106, 221, 1996.
427. Neubert, D., Wiesmueller, T., Abraham, K., Krowke, R., and Hegenmaier, H., Persistence of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) in hepatic and adipose tissue of marmoset monkeys, Arch. Toxicol., 64, 431, 1990.
428. Neubert, R., Golor, G., Maskow, L., Helge, H., and Neubert, D., Evaluation of possible effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and other congeners on lymphocyte receptor Callithix jacchus and man, Exp. Clin. Immunogenet., 11, 119, 1994.
429. Roegner, R. H., Grubbs, W. D., Wolfe, W. H., and Michalek, J. E., An epidemiologic investigation of health effects in air force personnel following exposure to herbicides, in Air Force Health Study, Vol. 6, Epidemiology Research Division, Armstrong Laboratory, Brooks Air Force Base, TX, 1991.
430. Wolfe, W. H., Michalek, J. E., Miner, J. C., Henriksen, G. L., and Swaby, J. A., Air Force Health Study: An epidemiologic investigation of health effects of air force personnel following exposure to herbicides, Vol. 2, Epidemiologic Research Division, Brooks Air Force Base, Texas, 1995.
431. Tonn, T., Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Environ. Health Perspect., 104, 422, 1996.
432. Dewailly, E., Ayotte, P., Bruneau, S., Laliberte, C., and Muir, D. C. G., Inuit exposure of organochlorines through the aquatic food chain in Arctic Quebec, Environ. Health Perspect., 101, 618, 1993.
433. Weisglas-Kuperus, N., Sas, T. C. J., Koopman-Esseboom, C., van der Zwan, C. W., de Ridder, M. A. J., Beishuizen, A., Hooijkaas, H., and Sauer, P. J. J., Immunologie effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants, Pediatr. Res.,38, 404, 1995.
434. Leatherland, J. F., Field observations on reproductive and developmental dysfunction in introduced and native salmonids from the Great Lakes, J. Great Lakes Res., 19, 737, 1994.
435. Vanderpump, M. P., Tunbridge, W. M., and French, J. M., The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey, Clin. Endocrinol., 45, 55, 1995.
436. Robbins, S. L. and Kumar, V., Basic Pathology, 4th ed., W. B. Saunders Co., Philadelphia, 1987, 684.
437. Gaitan, E., Goitrogens in food and water, Ann. Rev. Nutr., 10, 21, 1990.
438. Osman, B. A., Ng, M. L., Bakar, A. A., and Khalid, B. A., The effect of cassava leave intake on thyroid hormone and urinary iodine, East Afr. Med. J., 70, 314, 1993.
439. Meyer, J. D., Gaitan, E., Merino, H., and Derouen, T. A., Geologic implications in the distribution of endemic goiter in Colombia, South America, Int. J. Epidemiol., 7, 25, 1978.
440. Gaitan, E., Merino, H., Rodriguez, G., Medina, P., Meyer, J. D., Derouen, T. A., and Maclennan, R., Epidemiology of endemic goitre in western Colombia, Bull. WHO, 56, 403, 1978.
441. Malamos, B., Koutras, D. A., Rigopoulos, G. A., Papapetrou, P. D., Gougas, E., Kelperi, H., Moraitopoulos, C., Davi, E., and Leonardopoulos, J., Endemic goiter in Greece: some new epidemiologic studies, J. Clin. Endocrin., 32, 130, 1971.
442. Vought, R. L., London, W. T., and Stebbing, G. E. T., Endemic goiter in northern Virginia, J. Clin. Endocrinol. Metab., 27, 1381, 1967.
443. Vought, R. L., Brown, F. A., and Sibinovic, K. H., Antithyroid compounds produced by Escherichia coli: Preliminary report., J. Clin. Endocrinol. Metab., 38, 861, 1974.
444. Gaitan, E., Cooksey, R. C., Legan, J., Cruse, J. M., Lindsay, R. H., and Hill, J., Antithyroid and goitrogenic effects of coal-water extracts from iodine-sufficient goiter areas, Thyroid. Spring, 3, 49, 1993.
445. McClain, R. M., Thyroid gland neoplasia: Non-genotoxic mechanisms, Toxicol. Let., 64, 397, 1992.
446. Capen, C. C., Pathophysiology of chemical injury of the thyroid gland, Toxicol. Lett., 64-65, 381, 1992.
447. Dohler, K. D., Wong, C. C., and von Zur Muhlen, A., The rat as a model for the study of drug effects on thyroid function: Consideration of methodological problems, Pharmacol. Ther., 5, 305, 1979.
448. Pluim, H. J., DeVijlder, J. J. M., Loie, K., Kok, J. H., Vulsma, T., Vantijn, D. A., Van der Slikke, J. W., and Koppe, J. G., Effects of pre- and postnatal exposure to chlorinated dioxins and furans on human neonatal thyroid hormone concentrations, Environ. Health Perspect., 101, 504, 1993.
449. Murai, K., Okamura, K., and Tsuji, H., Thyroid function in Yusho patients exposed to polychlorinated biphenyls (PCB), Environ. Res., 44, 179, 1987.
450. Bastomsky, C. H., Enhanced thyroxine metabolism and high uptake goiters after a single dose of 2,3,7,8-TCDD, Endocrinology, 101, 292, 1977a.
451. Bastomsky, C. H., Goiters in rats fed polychlorinated biphenyls, Can. J. Physiol. Pharmacol., 55, 288, 1977b.
452. Arnold, D. L., Bryce, F., and Stapley, R., Toxicological consequences of Aroclor 1254 ingestion by female rhesus (Macaca mulatta) monkeys, Part 1A, Prebreeding phase: Clinical health findings, Food Chem. Toxicol., 31, 811, 1993.
453. Tryphonas, L., Carboneau, S., Tryphonas, H., and Zawidzka, Z., Comparative aspects of Arochlor 1254 toxicity in adult cynomologus and rhesus monkeys: a pilot study, Arch. Environ. Contam. Toxicol., 15, 159, 1986a.
454. Tryphonas, L., Arnold, D. L., and Zawldzka, Z., A pilot study in adult rhesus monkeys (A. mulatto) treated with Aroclor 1254 for two years, Toxicol Pathol, 14, 1, 1986b.
455. Zober, A., Ott, M. G., and Messerer, P., Morbidity follow-up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident, Occup. Environ. Med., 51, 479, 1994.
456. Seo, B-W, Li, M-H, Hansen, L. G., Moore, R. W., Peterson, R. E., and Schantz, S. L., Effects of gestational and lactational exposure to coplanar polychlorinated biphenyl (PCB) congeners or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thyroid hormone concentrations in weanling rats, Toxicol. Lett., 78, 253, 1995.
457. Juarez De Ku, L. M., Sharma-Stokkermans, M., and Meserve, L. A., Thyroxine normalizes polychlorinated biphenyls (PCB) dose-related depression of chlorine acetyltransferase (ChAT) activity in hippocampus and basal forebrain of 15-day-old rats, Toxicology, 94, 19, 1994.
458. Ness, D.K., Schantz,S.L.,Moshtaghian, J., and Hansen, L. G., Effects of prenatal exposure to specific PCB congeners on thyroid hormone concentrations and thyroid histology in the rat, Toxicol. Lett., 68, 311, 1993.
459. Lans, M. C., Brouwer, A., Koppe, J. G., and Vandenberg, M., Enzyme induction and alterations in thyroid hormone, vitamin A and K levels by TCDD in neonatal and maternal rats, Chemosphere, 20, 1129, 1990.
460. Morse, D. C., Koester, H. B. W. M., Smits van Prooijen, A. E., and Brouwer, A., Interference of PCBs in thyroid hormone metabolism: Possibile neurotoxic consequences in fetal and neonatal rats, Chemosphere, 25, 165, 1992.
461. Bastomsky, C. H., Murthy, P. V. N., and Banovac, K., Endocrinol., 98, 1309, 1976.
462. Lans, M. C., Spiertz, C., Brouwer, A., and Koeman, J. H., Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs, Eur. J. Pharmacol., 270, 129, 1994.
463. Bastomsky, C. H., Effects of a polychlorinated biphenyl mixture and DDT on biliary thyroxine excretion in rats, Endocrinology, 95, 1150, 1974.
464. Zhou, L. X., Dehal, S. S., Kupfer, D., Morrell, S., McKenzie, B. A., Eccleston E. D., Jr., and Holtzman, J. L., Cytochrome P540 catalyzed covalent binding of methoxychlor to rat hepatic microsomal iodothyronine 5′-monodeiodinase, Type I: Does exposure to methoxyclor disrupt thyroid hormone metabolism?, Arch. Biochem. Biophysics, 322, 390, 1995.